CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Drutz David Director | Sale | −7,827 | $6.93 | $54K | 41,958 |
| 2024-08-19 | Drutz David Director | Sale | −8,184 | $6.88 | $56K | 55,524 |
| 2022-12-22 | Pisano Wayne Director | Sale | −20,000 | $15.01 | $300K | 8,498 |
| 2022-08-31 | Garg Vipin K President and CEO | Sale | −20,000 | $20.02 | $400K | 236,797 |
| 2022-08-12 | GILL JOHN Director | Sale | −2,714 | $15.00 | $41K | 2,771 |
| 2022-08-12 | Garg Vipin K President and CEO | Sale | −15,000 | $15.06 | $226K | 259,804 |
| 2022-07-05 | Roberts M Scot Chief Scientific Officer | Sale | −10,182 | $12.00 | $122K | 8,305 |
| 2022-07-01 | Roberts M Scot Chief Scientific Officer | Sale | −26,982 | $12.00 | $324K | 17,700 |
| 2022-06-29 | Roberts M Scot Chief Scientific Officer | Sale | −5,462 | $12.00 | $66K | 17,700 |
| 2022-06-27 | Roberts M Scot Chief Scientific Officer | Sale | −37,352 | $12.00 | $448K | 17,700 |
| 2022-06-27 | Jorkasky Diane Director | Sale | −17,610 | $11.75 | $207K | 0 |
| 2022-02-28 | Harris Matthew Scott Chief Medical Officer | Sale | −30,000 | $7.52 | $226K | 11,545 |
| 2021-03-01 | Hodges Philip Director | Sale | −6,000 | $16.08 | $96K | 8,731 |
| 2020-12-01 | Hodges Philip Director | Sale | −1,227 | $13.54 | $17K | 0 |
| 2020-11-30 | Hodges Philip Director | Sale | −2,500 | $12.00 | $30K | 14,731 |
| 2020-11-30 | GILL JOHN Director | Sale | −8,425 | $11.92 | $100K | 11,199 |
| 2020-11-12 | Schafer Klaus Director | Sale | −10,150 | $9.91 | $101K | 6,900 |
| 2020-11-12 | Pisano Wayne Director | Sale | −10,352 | $9.90 | $102K | 8,498 |
| 2020-11-12 | Harris Matthew Scott Director | Sale | −4,015 | $10.02 | $40K | 4,069 |
| 2020-05-15 | VELOCITY PHARMACEUTICAL HOLDINGS LLC 10% owner | Sale | −30,622 | $4.65 | $142K | 1,687,250 |
Page 1 of 2 · 21 trades